APTAH BRAZIL
A drug design algorithm that makes the drug discovery process more agile. our process is very helpful to other companies because of the high costs in lead optimization and customisation of new drugs. Our competitive advantage is the time reduction that we bring to the drug discovery process, also reducing costs and risks in the drug discovery process. We have already developed new molecules for cancer treatment, anti-inflammatory drugs and new oligonucleotides to gene therapy.
APTAH BRAZIL
Industry:
Bioinformatics Biopharma Biotechnology Chemical Engineering Genetics Health Care Health Diagnostics Life Science Pharmaceutical
Founded:
2018-10-26
Address:
Goiânia, Goias, Brazil
Country:
Brazil
Website Url:
http://www.aptah-bio.com
Total Employee:
1+
Status:
Active
Contact:
5561996363616
Email Addresses:
[email protected]
Similar Organizations
Aspen Biopharma Labs
Aspen Biopharma Labs is a biotech company that supplies API impurities, chemicals, and drug ingredients.
inqaba biotec
inqaba biotec is a genomics research center that offers genetic testing, DNA sequencing, genetic fingerprinting, and genetic health testing.
leading biology inc
Leading Biology Inc. is an innovative high-tech company which produces bio-products for a wide range of research and medical fields.
Medein Sciences
Medein Sciences provides health diagnostics and support service for biotech, pharmaceutical, cosmetic industries.
Sedna.bio
Sedna is a health innovation company that will accelerate the next revolution in drug development.
Synvia
Synvia is a holding company that focuses on innovation in drug studies, drug development and performing toxicological test services.
Ventura Ventures
The first dedicated pre-seed VC serving innovative founders across Ventura and Santa Barbara Counties
yuFlu
yuFlu is a social impact, biotech startup focused on reducing "flu-like" illness.
Founder
Official Site Inspections
http://www.aptah-bio.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Aptah Brazil"
Aptah Bio - Crunchbase Company Profile & Funding
Imagine a world where age-related diseases are things of the past! That’s the …See details»
Aptah Bio - LinkedIn
Aptah Bio is delighted to announce that we have been awarded a $3 million non-dilutive grant, designed to advance our innovative research in oncology and …See details»
Aptah Biosciences - PitchBook
Aptah Biosciences General Information Description. Developer of novel RNA …See details»
Aptah Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Aptah Bio, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Nervous System Diseases, Neoplasms, Endocrinology and Metabolic …See details»
Aptah Bio - BIO International Convention 2025
Aptah Bio. Biotech or pharma, therapeutic R&D Aptah Bio has developed the RNA Widespread Correctio (RNA WiCo), the first and only technology platform able to correct genome-wide …See details»
Members | Longevity Biotechnology Association
Co-Founder of Beyond Aging, an organization dedicated to growing the funding environment for longevity research, and CEO of Helpwear, a medical device …See details»
About | Aptah Biosciences
Aptah Bio Inc. 930 MBC Brittan Ave . San Carlos – 94070 California . USA ...See details»
Aptah Bio - Work in biotech
Aptah Bio is a biotechnology company focused on developing innovative therapies for age-related diseases. Their proprietary technology platform, RNA WiCo™ (RNA Widespread Correction), …See details»
Contact - Aptah Biosciences
Reach out, share a question. fill out the form and we’ll respond as soon as possible.See details»
Aptah Bio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Jan 20, 2021: Seed Round - Aptah Bio . 1: …See details»
Technology - Aptah Biosciences
At Aptah, our mission is to revolutionize the biotech industry through groundbreaking research and development. We are committed to delivering innovative solutions that improve the lives of …See details»
Aptah Bio - Contacts, Employees, Board Members, Advisors
Experience the new Crunchbase, powered by AI . Organization. Aptah BioSee details»
Aptah Brazil - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 5561996363616 A drug design algorithm that makes the drug discovery process more agile. our process is very helpful to other companies …See details»
APT-002(Aptah Biosciences) - Drug Targets, Indications, Patents
APT-002(Aptah Biosciences), Initially developed by Aptah Bio, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases, Active Indication: …See details»
The ability to replicate human aging in a laboratory is an exciting ...
Aug 14, 2024 In response to this challenge, Aptah Bio partnered with Prof. Muotri to address the gap between the problem and the long-awaited solution. Aptah’s proprietary rejuvenation …See details»
Aptah Bio - Updates, News, Events, Signals & Triggers - Crunchbase
Biotech company developing the next generation of RNA therapies for age-related diseases.See details»
BIO Announces Dedicated Focus on Human Health and …
3 days ago Washington, DC, May 28, 2025 – The Biotechnology Innovation Organization (BIO) today announced plans to dedicate its focus entirely to human health and to transition the work …See details»
APT20TTMG - Drug Targets, Indications, Patents - Synapse
May 8, 2025 APT20TTMG, Initially developed by Aptah Bio, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases, Active Indication ...See details»
APT-007(Aptah Biosciences) - Drug Targets, Indications, Patents
APT-007(Aptah Biosciences), Initially developed by Aptah Bio, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication ...See details»
APT-005(Aptah Biosciences) - Drug Targets, Indications, Patents
APT-005(Aptah Biosciences), Initially developed by Aptah Bio, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Nervous System Diseases,Endocrinology and …See details»